Clinical Neurophysiology and Peripheral Neuropathy

Clinical Neurophysiology and Peripheral Neuropathy Research

The Department of Clinical Neurophysiology has a major commitment to the conduct of randomized controlled trials of new treatments for a variety of peripheral neuropathies. Particular areas of interest have been the diabetic neuropathies, chemotherapy induced neuropathies and the demyelinating neuropathies.

An important role of the department is in the safety monitoring of new drugs (either TGA approved or research related) with potentially neurotoxic side effects. Adverse events such as peripheral neuropathy or optic neuropathy can be identified at a subclinical stage using neurophysiologic techniques.

Current initiatives include enhancing the assessment of small fibre neuropathies with utilization of quantitative sensory testing, and development of further tests to evaluate autonomic function.